DK0538404T3 - Fibroblaste vækstfaktorreceptorer - Google Patents

Fibroblaste vækstfaktorreceptorer

Info

Publication number
DK0538404T3
DK0538404T3 DK91915163T DK91915163T DK0538404T3 DK 0538404 T3 DK0538404 T3 DK 0538404T3 DK 91915163 T DK91915163 T DK 91915163T DK 91915163 T DK91915163 T DK 91915163T DK 0538404 T3 DK0538404 T3 DK 0538404T3
Authority
DK
Denmark
Prior art keywords
domain
growth factor
factor receptors
fibroblastic growth
repeats
Prior art date
Application number
DK91915163T
Other languages
Danish (da)
English (en)
Inventor
Craig A Dionne
Gregg Crumley
Michael C Jaye
Joseph Schlessinger
Original Assignee
Rhone Poulenc Rorer Internat H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24193610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0538404(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Internat H filed Critical Rhone Poulenc Rorer Internat H
Application granted granted Critical
Publication of DK0538404T3 publication Critical patent/DK0538404T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK91915163T 1990-07-06 1991-07-03 Fibroblaste vækstfaktorreceptorer DK0538404T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54958790A 1990-07-06 1990-07-06
PCT/US1991/004745 WO1992000999A1 (en) 1990-07-06 1991-07-03 Fibroblast growth factor receptors

Publications (1)

Publication Number Publication Date
DK0538404T3 true DK0538404T3 (da) 2003-10-13

Family

ID=24193610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915163T DK0538404T3 (da) 1990-07-06 1991-07-03 Fibroblaste vækstfaktorreceptorer

Country Status (10)

Country Link
US (1) US6344546B1 (de)
EP (2) EP0538404B1 (de)
JP (2) JP3615220B2 (de)
AT (1) ATE243253T1 (de)
AU (1) AU662107B2 (de)
CA (1) CA2086425C (de)
DE (1) DE69133281T2 (de)
DK (1) DK0538404T3 (de)
ES (1) ES2204886T3 (de)
WO (1) WO1992000999A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228609B1 (en) * 1992-07-09 2001-05-08 Systemix, Inc. Soluble Flk-2 sequence
EP0850055B1 (de) 1995-09-11 2005-06-29 Osteoarthritis Sciences, Inc. Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
US6214795B1 (en) 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
EP1141339A4 (de) * 1998-12-31 2002-04-17 Advanced Res & Tech Inst Menschlicher fibroblasten-wachstumsfaktor-rezeptor 1 als co-rezeptor zur infektion mit einem adeno-assoziiertem virus
US6657078B2 (en) * 2001-02-07 2003-12-02 Celanese International Corporation Low energy carbonylation process
CA2614039C (en) * 2005-07-22 2015-10-13 Five Prime Therapeutics, Inc. Compositions and methods of treating disease with fgfr fusion proteins
CL2007003411A1 (es) 2006-11-28 2008-07-04 Centelion Proteina fusion que consiste en una region fc de una inmunoglobulina con un fragmento o dominio soluble de un receptor para fgf; polinucleotido que la codifica y vector y celula que lo comprenden; composicion farmaceutica que comprende la proteina fu
JOP20190083A1 (ar) 2008-06-04 2017-06-16 Amgen Inc بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
CN102171343B (zh) 2008-08-04 2017-07-14 戊瑞治疗有限公司 Fgfr细胞外结构域酸性区突变蛋白
UA105016C2 (uk) 2008-10-10 2014-04-10 Амген Інк. Fgf21 мутанти і їх застосування
KR101860572B1 (ko) 2009-05-05 2018-05-24 암젠 인크 Ｆｇｆ２１ 돌연변이체 및 이의 용도
EP2427207B1 (de) 2009-05-05 2017-08-16 Amgen, Inc Fgf21-mutanten und ihre verwendungen
CA2764835A1 (en) * 2009-06-17 2010-12-23 Amgen Inc. Chimeric fgf19 polypeptides and uses thereof
US8445445B2 (en) 2009-09-15 2013-05-21 Five Prime Therapeutics, Inc. Method of promoting hair growth using FGFR4 extracellular domains
CA2780457A1 (en) 2009-11-13 2011-05-19 Five Prime Therapeutics, Inc. Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2
EP2506861A1 (de) * 2009-12-02 2012-10-10 Amgen Inc. Bindeproteine zur bindung von humanem fgfr1c, humanem b-klotho sowie humanem fgfr1c als auch humanem b-klotho
UA109888C2 (uk) * 2009-12-07 2015-10-26 ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
EP2512501A4 (de) 2009-12-17 2014-01-01 Five Prime Therapeutics Inc Haarwuchsverfahren unter verwendung extrazellulärer fgfr3-domänen
JP2013529076A (ja) 2010-05-11 2013-07-18 アベオ ファーマシューティカルズ， インコーポレイテッド 抗ｆｇｆｒ２抗体
US8481038B2 (en) 2010-11-15 2013-07-09 Five Prime Therapeutics, Inc. Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
CA2817583A1 (en) 2010-11-15 2012-05-24 Five Prime Therapeutics, Inc. Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins
US8951972B2 (en) 2010-12-09 2015-02-10 Five Prime Therapeutics, Inc. FGFR1 extracellular domain combination therapies for lung cancer
EP2780033B1 (de) 2011-11-14 2019-05-08 Five Prime Therapeutics, Inc. Eine fgfr1 extrazelluläre domäne zur behandlung von krebs mit einer fgfr1 gen vervielfältigung
EP2964260A2 (de) 2013-03-06 2016-01-13 F. Hoffmann-La Roche AG Verfahren zur behandlung und prävention einer antikrebsmittelresistenz
CN107073121A (zh) 2014-06-13 2017-08-18 基因泰克公司 治疗及预防癌症药物抗性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001466D0 (en) * 1990-01-23 1990-03-21 Erba Carlo Spa Extracellular form of the human fibroblast growth factor receptor
ES2133271T3 (es) * 1989-07-06 1999-09-16 Univ California Receptores para factores de crecimiento de fibroblastos.

Also Published As

Publication number Publication date
EP0538404A4 (en) 1993-05-26
DE69133281D1 (de) 2003-07-24
CA2086425A1 (en) 1992-01-07
JP3996084B2 (ja) 2007-10-24
EP1403285A1 (de) 2004-03-31
ATE243253T1 (de) 2003-07-15
US6344546B1 (en) 2002-02-05
AU8427391A (en) 1992-02-04
WO1992000999A1 (en) 1992-01-23
ES2204886T3 (es) 2004-05-01
CA2086425C (en) 2006-01-17
JPH05508550A (ja) 1993-12-02
JP2004041176A (ja) 2004-02-12
EP0538404A1 (de) 1993-04-28
JP3615220B2 (ja) 2005-02-02
EP0538404B1 (de) 2003-06-18
DE69133281T2 (de) 2004-05-06
AU662107B2 (en) 1995-08-24

Similar Documents

Publication Publication Date Title
DK0538404T3 (da) Fibroblaste vækstfaktorreceptorer
NO931955L (no) Reseptorer for leukemiinhiberende faktor
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
AR017510A1 (es) Polinucleotido aislado o recombinante, vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para ladeteccion de un polinucleotido, compuesto de union, metodo de empleo del compuesto de union, polipeptido antigenico aislado o substancialmente puro, ymet
DE69130506D1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
DK0618976T3 (da) Syntetisk DNA-sekvens med forbedret insekticid virkning i majs
DK1482042T3 (da) Aktive og inaktive CC-kemokinreceptorer og nukleinsyremolekyler der koder for receptoren
HUP0001650A2 (hu) Javított expressziós vektorok
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
DE69737978D1 (de) Als 2f1 bezeichnetes rezeptorprotein
IL100343A0 (en) G protein coupled glutamate receptors
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
YU79491A (sh) Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina
NO940736L (no) DNA sekvenser som koder for gelonin polypeptid
ATE233788T1 (de) Interleukin-15-rezeptoren
DK0804577T3 (da) cDNA, der koder en BMP type II receptor
NO922421L (no) Collagenbindende protein, samt fremstilling derav
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
PT773999E (pt) Receptor orfao or-1 pertencente a familia de receptores nucleares
DE69333284D1 (de) Polypeptide mit serotoninerger (5ht5a) rezeptor-aktivität, für sie kodierende nukleinsäuren und ihre verwendung
DK0946591T3 (da) Klonede glucagon-lignende peptid-2 receptorer
ATE454450T1 (de) Proteine, das auf hämatopoietischen stammzellen der lymphoid und nk linien zu finden ist, und verwendungen davon
ATE410513T1 (de) 'patched-2' protein aus wirbeltieren
DE69130675D1 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
NO996228L (no) Polynucleotid som koder et polypeptid med heparanaseaktivitet, og ekspresjon av samme i transduserte celler